Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Apyx Medical (APYX) Raw Materials (2017 - 2018)

Historic Raw Materials for Apyx Medical (APYX) over the last 2 years, with Q4 2018 value amounting to $4.5 million.

Apyx Medical's Raw Materials fell 1243.46% to $4.5 million in Q4 2018 from the same period last year, while for Dec 2018 it was $4.5 million, marking a year-over-year decrease of 1243.46%. This contributed to the annual value of $4.5 million for FY2018, which is 1243.46% down from last year.
Per Apyx Medical's latest filing, its Raw Materials stood at $4.5 million for Q4 2018, which was down 1243.46% from $5.2 million recorded in Q4 2017.
In the past 5 years, Apyx Medical's Raw Materials registered a high of $5.2 million during Q4 2017, and its lowest value of $4.5 million during Q4 2018.